We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Schering-Plough has reached an agreement with the Justice Department and the U.S. Attorney's Office for the Eastern District of Pennsylvania in which it will pay $345 million to resolve criminal and civil charges for illegal pricing activities.
Mylan Laboratories plans to acquire King Pharmaceuticals in a $4 billion stock swap that will give Mylan access to four of King’s brand drugs, which generate sales more than $100 million each.
Bayer has acquired the OTC drug business of Roche for approximately $2.96 billion, a transaction that makes the company one of the top three OTC businesses worldwide.
Abbott Laboratories has agreed to settle two lawsuits filed by an AIDS advocacy group alleging the drug company was trying to manipulate the HIV/AIDS drug market.
Swiss drugmaker Novartis recently confirmed that it is considering construction of a large drug manufacturing plant in Singapore, a country that is drawing increased interest from pharmaceutical companies worldwide.